The FDA has approved use of GlaxoSmithKline’s Boostrix (Tdap) vaccine for use during the third trimester of pregnancy, for prevention of pertussis (whooping cough) in infants younger than two ...
Hosted on MSN10mon
Vaccines missing as whooping cough cases on the riseAccording to the Health Ministry’s chief expert in pediatrics, Elena Prokopová, 13-year-old children are vaccinated with the Boostrix polio vaccine. “This vaccine is out of stock frequently ...
In the context of boostrix, Government initiatives aim to increase the administration of the Tdap vaccine to prevent diseases such as tetanus, diphtheria, and pertussis whooping cough ...
Similar to Sanofi Pasteur, they also label pre-filled syringes and employ vial caps with a unique color to differentiate each of its vaccines and have a statement on the packaging for Boostrix ...
The company's consolidated net profit jumped multifold to Rs 230 crore as compared to Rs 46 crore a year ago in the December ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results